BRIVLERA

Product Overview

About BRIVLERA

BRIVLERA is a prescription medication containing the active ingredient Brivaracetam, used in the treatment of epilepsy. It belongs to a class of antiepileptic drugs known as pyrrolidine derivatives.

Key Benefits & Uses

• Treatment of partial-onset seizures in adults and adolescents 12 years of age and older with epilepsy.
• Treatment of primary generalized tonic-clonic seizures in adults and adolescents 12 years of age and older with epilepsy.
• Adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in adults and children 4 years of age and older with epilepsy.

Active Ingredient & Action

Brivaracetam, the active ingredient in BRIVLERA, is a selective, high-affinity ligand for the synaptic vesicle protein SV2A. It is believed to modulate neurotransmitter release through this binding. By inhibiting excessive neuronal activity, Brivaracetam helps to reduce the frequency and severity of seizures.

Important Notes

BRIVLERA is available in various strengths and should be taken exactly as prescribed by a healthcare professional. It is essential to follow the recommended dosage and not to exceed the prescribed amount. Patients should also inform their doctor about any medical history, allergies, or current medications before starting treatment with BRIVLERA.